86627-07-8

Basic information

• Product Name: 4,6-DICHLORO-2[[(4-METHOXYPHENYL)METHYL]THIO]PYRIMIDINE
• Synonyms: 4,6-DICHLORO-2[[(4-METHOXYPHENYL)METHYL]THIO]PYRIMIDINE
• CAS NO: 86627-07-8
• Molecular Formula: C₁₂H₁₀Cl₂N₂OS
• Molecular Weight: 301.19
• Mol File: 86627-07-8.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4,6-DICHLORO-2[[(4-METHOXYPHENYL)METHYL]THIO]PYRIMIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4,6-DICHLORO-2[[(4-METHOXYPHENYL)METHYL]THIO]PYRIMIDINE(86627-07-8)
• EPA Substance Registry System: 4,6-DICHLORO-2[[(4-METHOXYPHENYL)METHYL]THIO]PYRIMIDINE(86627-07-8)

Safety Data

• Hazardous Substances Data: 86627-07-8(Hazardous Substances Data)

Upstream product

• 86627-06-7 2-<(4-methoxybenzyl)thio>-4,6(1H,5H)-pyrimidinedione 
• 824-94-2 p-methoxybenzyl chloride 

Downstream Products

• 86627-09-0 2-p-Methoxybenzylthio-4-chloro-6-(N-methyl-2,3-xylidino)-pyrimidine 
• 86627-08-9 <4-chloro-6-<(2,3-dimethylphenyl)amino>-2-(4-methoxybenzyl)thio>pyrimidine 
• 166751-67-3 4-amino-6-chloro-2-(4-methoxyphenylmethylthio)-pyrimidine 
• 1416899-26-7 [6-chloro-2-(4-methoxy-benzylsulfanyl)-pyrimidin-4-yl]-(5-methyl-1H-pyrazol-3-yl)-amine 
• 1253847-01-6 8-ethyl-2-(4-methoxybenzylsulfanyl)-9-methyl-6-morpholino-9H-purine 
• 869119-61-9 2-(4-methoxybenzylsulfanyl)-4-methylamino-6-morpholino pyrimidine 
• 869119-26-6 5-amino-2-(4-methoxybenzylsulfanyl)-6-methylamino-4-morpholinopyrimidine 
• 1253847-02-7 2-(3-amino-4-methoxybenzylsulfanyl)-8-ethyl-9-methyl-6-morpholino-9H-purine 
• 1253848-91-7 8-ethyl-9-methyl-6-morpholino-2-(3-nitro-4-methoxybenzylsulfanyl)-9H-purine 
• 1253847-27-6 2-(3-acetylamino-4-methoxybenzylsulfanyl)-8-ethyl-9-methyl-6-morpholino-9H-purine 
• 869119-60-8 4-chloro-2-(4-methoxybenzylsulfanyl)-6-methylaminopyrimidine 
• 1253847-64-1 2-[3-(2-tert-butoxycarbonylaminoacetylamino)-4-methoxybenzyl sulfanyl]-8-ethyl-9-methyl-6-morpholino-9H-purine 

Relevant articles and documents

PURINE DERIVATIVE AND ANTITUMOR AGENT USING SAME

Disclosed are: a novel purine derivative, a composition thereof, a method for treating tumor using the purine derivative, and an antitumor agent using the purine derivative. Specifically disclosed is a compound represented by formula (I), or a pharmaceuti

Pyrimidine-thioalkyl and alkylether compounds

The subject invention relates to pyrimidine-thioalkyl and alkylether compounds of Formula I and pyrimidine-thioalkyl and alkylethers of Formula IA, namely the compounds of Formula I whereR4 is selected from the group consisting of -H or -NRsub

Pyrimidine and s-triazine derivatives with antilipidemic activity

Pyrimidine and s-triazine derivatives of formula (I) (I) in which X=CH or N; Y=for example halogen, alkoxy; W=for example -S-CH2-COOH, -O-CH2-COO alkyl, -NH-CH2-CONHCH2CH2OH; Z=for example 2,3-xylidino, and methods for the preparation thereof are described. The compounds show high antilipemic activity.